BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 20535052)

  • 1. Liquid chromatography-tandem mass spectrometry outperforms fluorescence polarization immunoassay in monitoring everolimus therapy in renal transplantation.
    Moes DJ; Press RR; de Fijter JW; Guchelaar HJ; den Hartigh J
    Ther Drug Monit; 2010 Aug; 32(4):413-9. PubMed ID: 20535052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a fluorescent polarization immunoassay for whole blood everolimus determination using samples from renal transplant recipients.
    Salm P; Warnholtz C; Boyd J; Arabshahi L; Marbach P; Taylor PJ
    Clin Biochem; 2006 Jul; 39(7):732-8. PubMed ID: 16725133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 12-hour area under the curve cyclosporine concentrations determined by a validated liquid chromatography-mass spectrometry procedure compared with fluorescence polarization immunoassay reveals sirolimus effect on cyclosporine pharmacokinetics.
    Napoli KL
    Ther Drug Monit; 2006 Dec; 28(6):726-36. PubMed ID: 17164687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between everolimus blood concentration assessed using the Innofluor Certican Fluorescence Polarization Immunoassay and the Architect i System sirolimus chemiluminescent microparticle immunoassay.
    Coentrão L; Carvalho C; Sampaio S; Oliveira JG; Pestana MI
    Transplant Proc; 2010 Jun; 42(5):1867-9. PubMed ID: 20620539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of fluorescent polarization immunoassay (FPIA) versus HPLC to measure everolimus blood concentrations in clinical transplantation.
    Khoschsorur G; Fruehwirth F; Zelzer S; Stettin M; Halwachs-Baumann G
    Clin Chim Acta; 2007 May; 380(1-2):217-21. PubMed ID: 17320846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
    Koster RA; Dijkers EC; Uges DR
    Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between a liquid chromatography-tandem mass spectrometry assay and a fluorescent polarization immunoassay to measure whole blood everolimus concentration in heart and renal transplantations.
    Dailly E; Deslandes G; Hourmant M; Petit T; Renaud C; Treilhaud M; Jolliet P
    J Clin Lab Anal; 2008; 22(4):282-5. PubMed ID: 18623123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Innofluor certican assay with HPLC-UV for the determination of everolimus concentrations in heart transplantation.
    Baldelli S; Crippa A; Gabrieli R; Fiocchi R; Perico N; Merlini S; Ottomano C; Cattaneo D
    Clin Biochem; 2006 Dec; 39(12):1152-9. PubMed ID: 17054930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of everolimus metabolite patterns in trough blood samples of kidney transplant patients.
    Strom T; Haschke M; Zhang YL; Bendrick-Peart J; Boyd J; Roberts M; Arabshahi L; Marbach P; Christians U
    Ther Drug Monit; 2007 Oct; 29(5):592-9. PubMed ID: 17898649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method.
    Johnson-Davis KL; De S; Jimenez E; McMillin GA; De BK
    Ther Drug Monit; 2011 Aug; 33(4):453-9. PubMed ID: 21743377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
    Westley IS; Taylor PJ; Salm P; Morris RG
    Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
    Rodríguez E; Delucchi MA; Cano F; Valdebenito S; Castillo MC; Villegas R
    Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical performance of QMS everolimus assay on ortho Vitros 5,1 FS fusion analyzer: measuring everolimus trough levels for solid organ transplant recipients.
    Shu I; Wright AM; Chandler WL; Bernard DW; Wang P
    Ther Drug Monit; 2014 Apr; 36(2):264-8. PubMed ID: 24232125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive quantification of sirolimus and everolimus by LC-MS/MS with online sample cleanup.
    Mueller DM; Rentsch KM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Apr; 878(13-14):1007-12. PubMed ID: 20308022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two rapid ultra performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay.
    Tszyrsznic W; Borowiec A; Pawlowska E; Jazwiec R; Zochowska D; Bartlomiejczyk I; Zegarska J; Paczek L; Dadlez M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 928():9-15. PubMed ID: 23584041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography-mass spectrometry.
    van der Heijden J; de Beer Y; Hoogtanders K; Christiaans M; de Jong GJ; Neef C; Stolk L
    J Pharm Biomed Anal; 2009 Nov; 50(4):664-70. PubMed ID: 19155152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of QMS everolimus assay using Hitachi 917 Analyzer: comparison with liquid chromatography/mass spectrometry.
    Dasgupta A; Davis B; Chow L
    Ther Drug Monit; 2011 Apr; 33(2):149-54. PubMed ID: 21266941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an immunoassay (Abbott-IMX Analyzer) allowing routine determination of sirolimus: comparison with LC-MS method.
    Bargnoux AS; Bonardet A; Chong G; Garrigue V; Deleuze S; Dupuy AM; Mourad G; Cristol JP
    Transplant Proc; 2006 Sep; 38(7):2352-3. PubMed ID: 16980087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the reintroduced MEIA assay with HPLC-MS/MS for the determination of whole-blood sirolimus from transplant recipients.
    Morris RG; Salm P; Taylor PJ; Wicks FA; Theodossi A
    Ther Drug Monit; 2006 Apr; 28(2):164-8. PubMed ID: 16628125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of everolimus QMS immunoassay on Architect ci4100 and liquid chromatography/mass spectrometry: lack of agreement in organ-transplanted patients.
    Hoffer E; Kurnik D; Efrati E; Scherb I; Karasik M; Ring G; Bentur Y
    Ther Drug Monit; 2015 Apr; 37(2):214-9. PubMed ID: 25162218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.